000			02095 a2200589 4500
005			20250516071117.0
264		0	_c20120618
008			201206s 0 0 eng d
022			_a1538-8514
024	7		_a10.1158/1535-7163.MCT-11-0412 _2doi
040			_aNLM _beng _cNLM
100	1		_aTai, Wei-Tien
245	0	0	_aDovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3. _h[electronic resource]
260			_bMolecular cancer therapeutics _cFeb 2012
300			_a452-63 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBenzenesulfonates _xpharmacology
650	0	4	_aBenzimidazoles _xchemistry
650	0	4	_aBlotting, Western
650	0	4	_aCarcinoma, Hepatocellular _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aMolecular Structure
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds
650	0	4	_aProtein Kinase Inhibitors _xchemistry
650	0	4	_aProtein Tyrosine Phosphatase, Non-Receptor Type 6 _xgenetics
650	0	4	_aPyridines _xpharmacology
650	0	4	_aQuinolones _xchemistry
650	0	4	_aRNA Interference
650	0	4	_aSTAT3 Transcription Factor _xgenetics
650	0	4	_aSorafenib
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aCheng, Ann-Lii
700	1		_aShiau, Chung-Wai
700	1		_aLiu, Chun-Yu
700	1		_aKo, Ching-Huai
700	1		_aLin, Mai-Wei
700	1		_aChen, Pei-Jer
700	1		_aChen, Kuen-Feng
773	0		_tMolecular cancer therapeutics _gvol. 11 _gno. 2 _gp. 452-63
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-11-0412 _zAvailable from publisher's website
999			_c21401849 _d21401849